Le Lézard
Classified in: Science and technology, Business
Subject: CON

Deltix CryptoCortex Trading Platform Integrates with TP ICAP's Fusion Digital Assets Exchange


The integration offers increased liquidity venues for institutional investors to trade digital assets

NEWTOWN, Pa., Dec. 6, 2023 /PRNewswire/ -- Deltix announced today that its CryptoCortex trading platform is now integrated with TP ICAP's Digital Assets exchange, known as Fusion.

DeltixLab is part of EPAM Systems, Inc., a leading digital transformation services and product engineering company. Its CryptoCortex software is the most advanced platform for the primary and secondary market trading of digital assets and cryptocurrencies. Designed to support the full life cycle within the trading ecosystem, it caters to the needs of both buy-side and sell-side clients, including exchanges, brokers, over-the-counter trading desks, and market makers.

"With the addition of Fusion to the Deltix CryptoCortex ecosystem, we have further increased the number of liquidity venues that our institutional investors can trade digital assets," said Ilya Gorelik, Head of EPAM's RAIL Lab.

Fusion Digital Assets combines TP ICAP's established expertise in operating venues and organizing execution with Fidelity Digital Assets' institutional-grade custodial capabilities and diversified liquidity from TP ICAP's global client base. The venue currently supports trading in Bitcoin and Ether against USD. Going forward, it will expand the assets it supports in line with client demand and add further custodians to develop a multi-custody model.

"Completing the CryptoCortex integration will allow clients to easily access our non-custodial exchange and the diversified liquidity we have sourced from the crypto-native landscape and TP ICAP's TradFi client base," said Tom Flanagan, Global Head of Execution and Liquidity Management.

The venue's core elements include:

For more information about Deltix's CryptoCortex platform or the integration with TP ICAP's Fusion Digital Assets exchange, please visit https://cryptocortex.io/.

About Deltix

DeltixLab is part of EPAM Systems, Inc., a leading digital transformation services and product engineering company. Its CryptoCortex trading platform is one of the most advanced platforms for primary and secondary markets of digital assets and cryptocurrencies. Designed to support the full life cycle within the trading ecosystem, it covers the needs of both buy-side and sell-side clients including exchanges, brokers, over-the-counter trading desks and market makers. www.epam.com

About TP ICAP Group Plc

TP ICAP is a world-leading markets infrastructure and data solutions provider. The Group connects buyers and sellers in wholesale financial, energy and commodities markets, across all major asset classes. Our broking services, data & analytics, and market intelligence are trusted by clients globally to help provide efficient and liquid markets. The Group operates from 60+ offices?across?28 countries, employing 5,200 people, including 2,600 brokers. By revenue, TP ICAP ranks in the top five liquidity venues globally alongside CME, ICE, Deutsche Boerse and LSEG. www.tpicap.com

SOURCE Deltix


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: